(Q35654046)

9 August 2017

title

Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates (English)

1 reference

9 August 2017

1

R N Jones

1 reference

9 August 2017

3

A L Barry

1 reference

9 August 2017

2

P C Fuchs

1 reference

9 August 2017

6

T L Gavan

1 reference

9 August 2017

4

L W Ayers

1 reference

9 August 2017

5

E H Gerlach

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 December 1986

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

published in

1 reference

9 August 2017

volume

30

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

961-963

1 reference

Cefuroxime, an in vitro Comparison with Six Other Cephalosporins.

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180632

Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180632

Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180632

Cefoperazone: A Review of Its Antimicrobial Spectrum, β-Lactamase Stability, Enzyme Inhibition, and Other in Vitro Characteristics

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180632

The beta-lactamases of gram-negative bacteria and their possible physiological role.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180632

In vitro activity of Ro 15-8074, a new oral cephalosporin, against Neisseria gonorrhoeae

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180632

LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disks

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180632

In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180632

Cefadroxil, a new broad-spectrum cephalosporin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180632

In-vitro activity of Ro-15-8074, a new oral cephalosporin

27 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3492961

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.30.6.961

1 reference

9 August 2017

1 reference

9 August 2017

1 reference